Spotlight Masimo: Sensing Better Health OutcomesOctober 07, 2022
Irvine, California-based Masimo makes non-invasive patient monitoring, measuring and sensing technologies that improve patient care in the hospital, the home, and on the go.
When the COVID-19 pandemic hit, Masimo found itself in a unique position to support the urgent needs of both clinicians and patients as demand for telehealth grew. The firm got to work in the early days of the outbreak, transforming a promising new technology in development for opioid overdose detection into a remote monitoring product to help alleviate overwhelmed care centers. The Masimo SafetyNet COVID is now in use around the world and since has been adapted to work with other technology platforms.
In 1989, founder Joe Kiani, who remains chairman and CEO today, set out to solve what he called “the unsolvable,” when he became convinced that using signal processing could solve problems in pulse oximetry that had long-plagued doctors. Today his advances in pulse oximetry technology help clinicians monitor more than 200 million patients worldwide and are the technology of choice in nine of the top 10 hospitals.
Masimo’s monitoring products work inside devices from a host of well-known manufacturers to improve patient outcomes, reduce the cost of care, and elevate non-invasive monitoring to new sites and expectations. The firm’s telehealth products, for example, combine superior sensor accuracy, automation, and cloud computing.
In the firm’s innovation lab, teams are at work on a non-invasive brain function monitor to fit the small foreheads of pediatric patients, a first-of-its-kind monitor to detect opioid overdoses at home, and a “rainbow SuperSensor” that collects 12 different blood constituent parameters continuously.
As of 9/30/22, Masimo Corp. was held in the Knowledge Leaders Strategy.